Wade, William E.; Martin, Bradley C.; Kotzan, Jeffrey A.; … - In: PharmacoEconomics 17 (2000) 1, pp. 1-12
Low molecular weight heparins (LMWHs) are increasingly being utilised as anticoagulants in healthcare settings. These agents offer several advantages over standard unfractionated heparin. Indications for LMWHs include deep vein thrombosis and pulmonary embolism prophylaxis, deep vein thrombosis...